Understanding Statin Non-Adherence: Knowing Which Perceptions and Experiences Matter to Different Patients

PLoS One. 2016 Jan 25;11(1):e0146272. doi: 10.1371/journal.pone.0146272. eCollection 2016.

Abstract

Background: Non-adherence to statins is substantial and is associated with numerous perceptions and experiences. However, time limits in clinical practice constrain in depth explorations of these perceptions and experiences.

Objectives: To propose and examine a strategy aimed at an efficient assessment of a wide array of perceptions and experiences regarding the efficacy, side effects, and practical problems of statins. Furthermore, to assess associations between this wide array of experiences and perceptions and non-adherence and to examine whether patients' 'perceived self-efficacy' moderated these associations.

Methods: Patients were recruited through community pharmacies. A wide array of specific patient perceptions and experiences was efficiently assessed using the electronic Tailored Medicine Inventory that allows people to skip irrelevant questions. Adherence was measured through self-report and pharmacy refill data.

Results: Of the two-hundred twenty-nine patients who participated (mean age 63.9, standard deviation 10.2), 40%-70% doubted the necessity of or lacked knowledge about the efficacy of statins, 20%-35% of the patients were worried about joint and muscle side effects or had experienced these, and 23% had encountered practical problems regarding information about statins, intake of tablets, the package, or the blister. Experiencing more practical problems was associated with increased unintentional non-adherence (Odds ratio 1.54, 95%CI:1.13-2.10, P < 0.01), whereas worrying about side effects was associated with increased intentional non-adherence (Odds ratio 1.90, 95%CI:1.17-3.08, P < 0.01). Higher 'perceived self-efficacy' did not moderate these associations.

Conclusions: Insight into patients' specific barriers with regard to appropriate statin use may reveal personal reasons for being non-adherent. The Tailored Medicine Inventory is a promising tool to devise individualized intervention strategies aimed at improving adherence by the clinician-patient alliance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Attitude to Health*
  • Cross-Sectional Studies
  • Drug Packaging
  • Drug-Related Side Effects and Adverse Reactions / psychology
  • Fear
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / drug therapy
  • Hypercholesterolemia / psychology*
  • Male
  • Medication Adherence / psychology*
  • Middle Aged
  • Netherlands / epidemiology
  • Patients / psychology*
  • Pharmacies / statistics & numerical data
  • Self Efficacy
  • Self Report
  • Surveys and Questionnaires

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors

Grants and funding

Funding was provided by the Netherlands Organisation for Health Research and Development (ZonMw), http://www.zonmw.nl/en/, grant number 152002028. ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.